KAATSU Training to Enhance Physical Function of Older Adults With Osteoarthritis (KAATSU-OA)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32607
- University of Florida
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 60 years and older
- Radiographic evidence of osteophytes
- Moderate to severe pain score (41-90 mm) recorded on 100-mm visual analog scale after 50-ft walk
- Bilateral standing anterior-posterior radiograph demonstrating Kellgren and Lawrence grade 2 or 3
- OA of the target knee
- Score ≤ 10 on the Short Physical Performance Battery, as an indicator of physical limitation
- Sedentary lifestyle, defined as <150 min/wk of moderate physical activity as assessed by CHAMPS questionnaire
- Willingness to participate in all study procedures
Exclusion Criteria:
- Failure to provide informed consent;
- Regular participation in resistance exercise training within the past 3 months
- Current involvement in supervised rehabilitation program
- Absolute contraindication(s) to exercise training according to American College of Sports Medicine guidelines
- Diagnosed peripheral vascular disease
- Ankle-brachial index < 0.95
- Resting office systolic blood pressure > 160 mm Hg or < 100 mm Hg
- Diastolic blood pressure > 100 mm Hg
- History or family history of thrombosis
- Resistant hypertension, defined by BP > 140/90 despite use of 3 or more antihypertensive medications
- Severe cardiac disease, including New York Heart Association Class III or IV congestive heart failure, clinically significant aortic stenosis, history of cardiac arrest or stroke, use of a cardiac defibrillator, or uncontrolled angina
- Deep venous thrombosis
- Known peripheral neuropathy
- History of rheumatoid arthritis
- Lower limb amputation
- Lives in a nursing home; (persons living in assisted or independent housing will not be excluded)
- Significant cognitive impairment, defined as a known diagnosis of dementia or a Mini-Mental State Examination exam score < 24
- Unable to communicate because of severe hearing loss or speech disorder;
- Severe visual impairment, which would preclude completion of the assessments and/or intervention
- Other significant co-morbid disease that would impair ability to participate in the exercise intervention
- Lives outside of the study site or is planning to move out of the area during the study timeframe
- Simultaneous participation in another intervention trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Resistance exercise
Traditional isotonic lower-extremity resistance training
|
|
|
Experimental: KAATSU exercise
Lower-extremity exercise with blood flow mildly restricted
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in isokinetic muscle strength
Time Frame: 6 weeks post-randomization, 12 weeks post-randomization
|
6 weeks post-randomization, 12 weeks post-randomization
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Short Physical Performance Battery score
Time Frame: 12-weeks post-randomization
|
12-weeks post-randomization
|
|
Change in self-paced walking speed
Time Frame: 6 weeks-post randomization, 12 weeks post-randomization
|
6 weeks-post randomization, 12 weeks post-randomization
|
|
Change in Late Life Disability Questionnaire score
Time Frame: 12 weeks post-randomization
|
12 weeks post-randomization
|
|
Change in Western Ontario and McMaster Osteoarthritis Index score
Time Frame: 12 weeks post-randomization
|
12 weeks post-randomization
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Thomas Buford, PhD, University of Florida
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRB201400300
- 1R21AR065039-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.